The pool of 66 samples was then processed for deconvolution of absolute immune signals, as described above, and resulted in a sub-cohort of 45 samples composed of 20 MYCN-amplified and 25 non-MYCN-amplified neuroblastoma tumors that are characterized by similar-low enrichment from immune cells (≤10%). Here, MYCN is linked to neuroblastoma.